| Dr Benjamin Jacob Pazin, MD | |
|
5301 S Congress Ave, Atlantis, FL 33462-1149 | |
| (412) 656-4926 | |
| Not Available |
| Full Name | Dr Benjamin Jacob Pazin |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 11 Years |
| Location | 5301 S Congress Ave, Atlantis, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093132268 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | ME130159 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jfk Medical Center | Atlantis, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| H2 Hospital Associates Llc | 2961839758 | 72 |
News Archive
In this Kaiser Health News column, Brian Klepper and David Kibbe write: "Many reformers undoubtedly believe that passage of the health overhaul law laid the issue to rest. But policy's wheels continue to turn, and the process is anything but over" (9/20).
First lady Laura Bush is becoming the "public face" of the U.S. government commitment to fight HIV/AIDS and address other humanitarian and social issues, the Washington Post reports.
The most widely used biomarkers for the early detection of Alzheimer's disease (AD) are currently the concentrations of beta-amyloid and phosphorylated Tau in cerebrospinal fluid. However, it has been observed that not all individuals with alterations in these biomarkers develop the disease.
Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTA(TM) (belimumab) for treating systemic lupus. A full presentation of results from BLISS-52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology. Both trials succeeded in meeting their primary endpoints, which should make BENLYSTA eligible for approval by the U.S. Food and Drug Administration (FDA).
› Verified 3 days ago
| Entity Name | H2 Hospital Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265073159 PECOS PAC ID: 2961839758 Enrollment ID: O20200217000272 |
News Archive
In this Kaiser Health News column, Brian Klepper and David Kibbe write: "Many reformers undoubtedly believe that passage of the health overhaul law laid the issue to rest. But policy's wheels continue to turn, and the process is anything but over" (9/20).
First lady Laura Bush is becoming the "public face" of the U.S. government commitment to fight HIV/AIDS and address other humanitarian and social issues, the Washington Post reports.
The most widely used biomarkers for the early detection of Alzheimer's disease (AD) are currently the concentrations of beta-amyloid and phosphorylated Tau in cerebrospinal fluid. However, it has been observed that not all individuals with alterations in these biomarkers develop the disease.
Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTA(TM) (belimumab) for treating systemic lupus. A full presentation of results from BLISS-52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology. Both trials succeeded in meeting their primary endpoints, which should make BENLYSTA eligible for approval by the U.S. Food and Drug Administration (FDA).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Benjamin Jacob Pazin, MD 5301 S Congress Ave, Atlantis, FL 33462-1149 Ph: (412) 656-4926 | Dr Benjamin Jacob Pazin, MD 5301 S Congress Ave, Atlantis, FL 33462-1149 Ph: (412) 656-4926 |
News Archive
In this Kaiser Health News column, Brian Klepper and David Kibbe write: "Many reformers undoubtedly believe that passage of the health overhaul law laid the issue to rest. But policy's wheels continue to turn, and the process is anything but over" (9/20).
First lady Laura Bush is becoming the "public face" of the U.S. government commitment to fight HIV/AIDS and address other humanitarian and social issues, the Washington Post reports.
The most widely used biomarkers for the early detection of Alzheimer's disease (AD) are currently the concentrations of beta-amyloid and phosphorylated Tau in cerebrospinal fluid. However, it has been observed that not all individuals with alterations in these biomarkers develop the disease.
Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today announced positive results from BLISS-76, the second of two large-scale phase III clinical trials of BENLYSTA(TM) (belimumab) for treating systemic lupus. A full presentation of results from BLISS-52 was recently shared at the 73rd Annual Scientific meeting of the American College of Rheumatology. Both trials succeeded in meeting their primary endpoints, which should make BENLYSTA eligible for approval by the U.S. Food and Drug Administration (FDA).
› Verified 3 days ago
Dr. Andrew Lelchuk, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 5301 S Congress Ave, Atlantis, FL 33462 Phone: 561-965-7300 | |
Mr. Hoang Minh Vo, D.O Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5301 S Congress Ave, Atlantis, FL 33462 Phone: 561-548-1750 Fax: 561-548-1755 |